APA (7th ed.) Citation

Kang, Y., Lee, J. S., Kim, H., Ryu, M., Park, Y. S., & Cho, H. Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Kang, Yoon-Koo, Jong Seok Lee, Hyung-Don Kim, Min-Hee Ryu, Young Soo Park, and Hyungwoo Cho. Phase 2 Study of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, and S-1 with Surgery and Adjuvant Durvalumab Plus S-1 for Resectable Locally Advanced Gastric Cancer. BMJ Publishing Group.

MLA (9th ed.) Citation

Kang, Yoon-Koo, et al. Phase 2 Study of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, and S-1 with Surgery and Adjuvant Durvalumab Plus S-1 for Resectable Locally Advanced Gastric Cancer. BMJ Publishing Group.